Clinical Trial Update: Ambroxol as a Treatment for Parkinson's Disease Dementia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring ambroxol as a treatment for Parkinson's disease dementia is ongoing or status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease Dementia

Drugs mentioned

• Ambroxol (Ambroxol)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Parkinson's Disease Dementia | Phase 2 | Status: UNKNOWN